Meeting to be held in Boston on April 8 and in New York on April 9 hosted by Piper Sandler.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBIO:
- BridgeBio reports pre-specified subgroup analysis of ATTRibute-CM trial
- Unusually active option classes on open March 31st
- BridgeBio initiated with a Buy at Redburn Atlantic
- BridgeBio announces Japanese MHLW approved acoramidis for treating ATTR-CM
- BridgeBio price target raised to $50 from $44 at JPMorgan